DE1965894C2 - 2-hydrazino-5-phenyl-3H-1,4-benzodiazepine derivatives and process for their preparation - Google Patents
2-hydrazino-5-phenyl-3H-1,4-benzodiazepine derivatives and process for their preparationInfo
- Publication number
- DE1965894C2 DE1965894C2 DE19691965894 DE1965894A DE1965894C2 DE 1965894 C2 DE1965894 C2 DE 1965894C2 DE 19691965894 DE19691965894 DE 19691965894 DE 1965894 A DE1965894 A DE 1965894A DE 1965894 C2 DE1965894 C2 DE 1965894C2
- Authority
- DE
- Germany
- Prior art keywords
- parts
- phenyl
- benzodiazepine
- hydrazino
- volume
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/20—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
- A47B—TABLES; DESKS; OFFICE FURNITURE; CABINETS; DRAWERS; GENERAL DETAILS OF FURNITURE
- A47B73/00—Bottle cupboards; Bottle racks
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F26—DRYING
- F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
- F26B3/00—Drying solid materials or objects by processes involving the application of heat
- F26B3/02—Drying solid materials or objects by processes involving the application of heat by convection, i.e. heat being conveyed from a heat source to the materials or objects to be dried by a gas or vapour, e.g. air
- F26B3/10—Drying solid materials or objects by processes involving the application of heat by convection, i.e. heat being conveyed from a heat source to the materials or objects to be dried by a gas or vapour, e.g. air the gas or vapour carrying the materials or objects to be dried with it
- F26B3/12—Drying solid materials or objects by processes involving the application of heat by convection, i.e. heat being conveyed from a heat source to the materials or objects to be dried by a gas or vapour, e.g. air the gas or vapour carrying the materials or objects to be dried with it in the form of a spray, i.e. sprayed or dispersed emulsions or suspensions
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Microbiology (AREA)
- Mechanical Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
aufgearbeitet, wobei 2-Hydrazino-5-phenyI-7-trifluormethylr3H-l,4-benzodiazepin als kristallines Pulver vom Schmelzpunkt 127° C (Sinterung) bzw. 133 bis 135°C(unter Aufschäumen) erhalten wird.worked up, with 2-hydrazino-5-phenyI-7-trifluoromethylr3H-1,4-benzodiazepine as a crystalline powder from melting point 127 ° C (sintering) or 133 to 135 ° C (with foaming) is obtained.
Elementaranalyse: Berechnet für Ci^Hi3F3N4: C6037 H4.12 N 17,60 Gefunden: C60,06H3,96N17,40Elemental analysis: Calculated for Ci ^ Hi 3 F 3 N 4 : C6037 H4.12 N 17.60 Found: C60.06H3.96N17.40
Diese Form ist für dieses Verfahren ebenfalls geeignet.This shape is also suitable for this procedure.
Die Verbindung der Formel (III) kann beispielsweise nach dem Verfahren hergestellt werden, das in Journal of Organic Chemistry« 29,231 (1964) beschrieben istThe compound of formula (III) can, for example be prepared according to the procedure outlined in Journal of Organic Chemistry «29, 231 (1964)
Der Alkylrest R5 ist vorzugsweise ein Alkylrest mit 1 bis 6 Koiilenstoffatomen, z. B. ein Methylrest, Äthylrest, Propylrest, Isopropyirest, Butylrest, sek.-Butylrest, tert-Butylrest, Aryl- oder Hexylrest Der Aralkylrest für den R5 steht ist z. B ein Benzyl- oder PhenyläthylrestThe alkyl radical R 5 is preferably an alkyl radical having 1 to 6 carbon atoms, e.g. For example, a methyl radical, ethyl radical, propyl radical, Isopropyirest, butyl, sec-butyl, tert-butyl, aryl or hexyl radical is The aralkyl group for R 5 is z. B a benzyl or phenylethyl radical
Die Reaktion wird im allgemeinen in Gegenwart eines Lösungsmittel (z.B. Methanol, Äthanol und wäßrige Gemische von Methanol und Äthanol) bei etwa Raumtemperatur oder gegebenenfalls unter Erhitzen zum Siedepunkt des verwendeten Lösungsmittels durchgeführt Das Hydrazin wird in einer Menge von etwa 1 bis 10 Mol pro MoI der Verbindung (III) verwendetThe reaction is generally carried out in the presence of a solvent (e.g. methanol, ethanol and aqueous mixtures of methanol and ethanol) at about room temperature or optionally with heating to the boiling point of the solvent used. The hydrazine is used in an amount of about 1 to 10 moles per mole of the compound (III) are used
Die in dieser Weise hergestellten 2-Hydrazino-'5-phenyl-3H-l,4-benzodiazepinderivate (I) können nach üblichen Methoden, beispielsweise durch Abdampfen des Lösungsmittels vom Reaktionsgemisch, isoliert werden.The 2-hydrazino-'5-phenyl-3H-l, 4-benzodiazepine derivatives (I) prepared in this way can by customary methods, for example by evaporation of the Solvent from the reaction mixture, are isolated.
Die neuen Verbindungen der Formel (I) sind wertvolle Zwischenprodukte fiür die Herstellung der neuen S-TriazoIo[4,3-aIl,4]-bfc;izodiazepine gemäß Stammpatent 19 55 349, die muskelersck äffende, beruhigende und dämpfende Wirkungen haben und daher wertvoll als Muskelrelaxantien, Antikonvulsiva, Sedativa, Tranquilizer sind.The new compounds of the formula (I) are valuable intermediates for the preparation of the new S-TriazoIo [4,3-aIl, 4] -bfc; izodiazepine according to Master patent 19 55 349, which have muscular aping, calming and dampening effects and therefore are valuable as muscle relaxants, anticonvulsants, sedatives, tranquilizers.
Zu einer Suspension von 3,4 Teilen 2-Amino-7-chlor-S-phenyl-SH-l.^-benzodiazepindihydrochlorid in 60 Raumteilen Methanol werden 1,25 Teile 80%iges Hydrazinhydrat gegeben. Die Suspension wird 40 Minuten gerührt, mit Wasser verdünnt und mit Methylenchlorid extrahiert Der Extrakt wird mit Wasser gewaschen und über wasserfreiem Natriumsulfat getrocknet, worauf das Lösungsmittel abgedampft wird. Der Rückstand wird aus einem Gemisch von Methylenchlorid und Benzol umkristallisiert, wobei 7-Chlor-2-hydrazino-5-phenyl-3H-l,4-benzodiazepin in Form von farblosen Prismen erhalten wird. Schmelzpunkt etwa 170° C (Bräunung); 202 bis 204° C (Zers.)To a suspension of 3.4 parts of 2-amino-7-chloro-S-phenyl-SH-l. ^ - benzodiazepine dihydrochloride in 60 Parts by volume of methanol are given 1.25 parts of 80% hydrazine hydrate. The suspension turns 40 Stirred minutes, diluted with water and extracted with methylene chloride. The extract is washed with Washed with water and dried over anhydrous sodium sulfate, whereupon the solvent was evaporated will. The residue is recrystallized from a mixture of methylene chloride and benzene, whereby 7-chloro-2-hydrazino-5-phenyl-3H-1,4-benzodiazepine is obtained in the form of colorless prisms. Melting point about 170 ° C (browning); 202 to 204 ° C (dec.)
Elementaranalyse: Berechnet WrC15HuCIN4: C 63,27 H 4,60 N 19,68 Gefunden: C 63,43 H 4,48 N 19,27Elemental Analysis: Calculated WrC 15 HuCIN 4 : C 63.27 H 4.60 N 19.68 Found: C 63.43 H 4.48 N 19.27
Zu einem Gemisch von 9,1 Teilen 2-Amino-5-phenyl-7-trifluormethyl-3H-l,4-benzodiazepin, 150 Raumteilen Äthanol und 3,6 Raumteilen Eisessig werden 4,5 Raumteile 100%iges Hydrazinhydrat gegeben. Das Gemisch wird 30 Minuten bei Raumtemperatur gerührt und auf die in Beispiel 1 beschriebene WeiseTo a mixture of 9.1 parts of 2-amino-5-phenyl-7-trifluoromethyl-3H-1,4-benzodiazepine, 150 parts by volume Ethanol and 3.6 parts by volume of glacial acetic acid are given 4.5 parts by volume of 100% hydrazine hydrate. That The mixture is stirred for 30 minutes at room temperature and in the manner described in Example 1
. Zu einem Gemisch von 5,6 Teilen 2-Amino-7-nitro-5-phenyI-3H-l,4-benzodiazepin, 200 Raumteilen Äthanol. To a mixture of 5.6 parts of 2-amino-7-nitro-5-phenyI-3H-1,4-benzodiazepine, 200 parts by volume of ethanol und 2,4 Raumteilen Eisessig werden unter Rühren 5 Raumteile 80%iges Hydrazinhydrat gegeben. Das Gemisch wird 30 Minuten bei Raumtemperatur gerührt und auf die in Beispiel 1 beschriebene Weise aufgearbeitet, wobei 2-Hydrazino-7-nitro-5-pheny-!-3H-and 2.4 parts by volume of glacial acetic acid, 5 parts by volume of 80% hydrazine hydrate are added with stirring. That The mixture is stirred for 30 minutes at room temperature and in the manner described in Example 1 worked up, with 2-hydrazino-7-nitro-5-pheny -! - 3H- 1,4-benzodiazepin als rötliche, viskose ölige Substanz erhalten wird.1,4-benzodiazepine as a reddish, viscous oily substance is obtained.
isobutyl-5-phenyl-3H-l,4-benzodiazepin und 25 Teilenisobutyl-5-phenyl-3H-1,4-benzodiazepine and 25 parts 100°/oigem Hydrazinhydrat in 400 Raumteilen Methanol100% hydrazine hydrate in 400 parts by volume of methanol werden 6 Teile Eisessig gegeben, während gerührt und6 parts of glacial acetic acid are added while stirring and
mit Eis gekühlt wird. Da* Gemisch wird dann 5 Stundenis cooled with ice. The * mixture will then be 5 hours bei Raumtemperatur gerührt Nach Zusatz von Wasserstirred at room temperature. After adding water zum Reaktionsgemisch wird mit Chloroform extrahiertthe reaction mixture is extracted with chloroform
über Natriumsulfat getrocknet Das Lösungsmittel wirddried over sodium sulfate. The solvent is abgedampft Durch Behandlung des Rückstandes mitevaporated by treating the residue with
phenyl-3H-1,4-benzodiazepin in Form von farblosenphenyl-3H-1,4-benzodiazepine in the form of colorless
hergestellten Produkt identisch.manufactured product identical.
Zu einer Lösung von 2 Teilen 7-Chlor-2-methyImercapto-5-phenyI-3H-l,4-benzodiazepin in 70 Raumteilen Äthanol werden 5 Raumteile 80%iges Hydrazinhydrat gegeben. Das Gemisch wird 3 Tage bei RaumtemperaTo a solution of 2 parts of 7-chloro-2-methyImercapto-5-phenyI-3H-1,4-benzodiazepine in 70 parts by volume Ethanol is given to 5 parts by volume of 80% hydrazine hydrate. The mixture is left for 3 days at room temperature tür stehengelassen. Nach dem Abdampfen des Lösungs mittels wird zum Rückstand eine geringe Wassermenge gegeben, wobei 7-ChIor-2-hydrazino-5-phenyl-3H- 1,4-benzodiazepin in Form von Kristallen erhalten wird. Durch Umkristallisation aus einem Gemisch vonleft the door. After evaporation of the solution by means of a small amount of water is added to the residue, 7-chloro-2-hydrazino-5-phenyl-3H-1,4-benzodiazepine being obtained in the form of crystals. By recrystallization from a mixture of Methylenchlorid und Benzol werden Kristalle vom Schmelzpunkt 175° C (Bräunung) und 205 bis 2070C (Zers.) erhalten. Dieses Produkt ist mit dem gemäß Beispiel 1 hergestellten Produkt identisch.Methylene chloride and benzene are obtained crystals of melting point 175 ° C (browning) and 205-207 0 C (dec.). This product is identical to the product produced according to Example 1.
Zu einer Lösung von 2,9 Teilen 7-Chlor-13-dihydro-5-phenyI-2H-l,4-benzodiazepin-2-thion in einem Gemisch von 2,5 Raumteifen Dimethylsulfoxyd und 100 Raumteilen Äthanol werden 5 Raumteile 80%igesTo a solution of 2.9 parts of 7-chloro-13-dihydro-5-phenyI-2H-1,4-benzodiazepine-2-thione in a mixture of 2.5 space hard dimethyl sulfoxide and 100 Parts of the volume of ethanol are 5 parts of the volume of 80% Hydrazinhydrat gegeben. Das Gemisch wird 24 Stunden stehengelassen. Nach dem Abdampfen des Lösungsmitteis unter vermindertem Druck wird der Rückstand mit Wasser verdünnt, worauf mit Methylenchlorid extrahiert wird. Die Methylenchloridschicht wird überGiven hydrazine hydrate. The mixture will last 24 hours ditched. After evaporation of the solvent under reduced pressure, the residue becomes with Diluted water, followed by extraction with methylene chloride. The methylene chloride layer is over Natriumsulfat getrocknet und das Lösungsmittel abgedampft. Durch Behandlung des Rückstandes mit Benzol wird 7-ChIor-2-hydrazino-5-phenyl-3H-1,4-benzodiaze-Din erhalten. Die Umkristallisation aus einem GemischDried sodium sulfate and evaporated the solvent. By treating the residue with benzene 7-chloro-2-hydrazino-5-phenyl-3H-1,4-benzodiaze-din is obtained. Recrystallization from a mixture
von Methylenchlorid und Benzol ergibt Kristalle vom Schmelzpunkt 205 bis 2070G (Zers.). Dieses Produkt ist identisch mit dem gemäß Beispiel 1 und 5 hergestellten Produktof methylene chloride and benzene gives crystals with a melting point of 205 to 207 0 G (decomp.). This product is identical to the product produced according to Examples 1 and 5
; Zu einer Lösung von 1,6 Teilen 7-Chlor-3-isobutyI-2-methylmercapto-5-phenyl-3H-l,4-benzodiazepin in 150 IRaumteüen Methanol werden 40 Teile lOOVoiges Hydrazinhydrat gegeben. Das Gemisch wird 4,5 to Stunden unter Rückfluß erhitzt und in Wasser gegossen, worauf mit Chloroform extrahiert wird. Die Chloroformschicht wird mit Wasser gewaschen und über !Natriumsulfat getrocknet worauf das Lösungsmittel abgedampft wird. Durch Behandlung des Rückstandes imit Diäthyläther wird 7-Chlor-2-hydrazino-3-isobutyl-5-phenyl-3H-l,4-benzodiazepin in Forra von Kristallen erhalten. Durch Umkristallisation aus einem Gemisch yoE Chloroform und η-Hexan werden farblose Kristalle vom Schmelzpunkt 168 bis 169° C erhalten.; To a solution of 1.6 parts of 7-chloro-3-isobutyl-2-methylmercapto-5-phenyl-3H-1,4-benzodiazepine 40 parts of lOOVoiges are in 150 parts of methanol Given hydrazine hydrate. The mixture is refluxed for 4.5 to hours and poured into water, followed by extraction with chloroform. The chloroform layer is washed with water and dried over sodium sulfate whereupon the solvent is evaporated. Treatment of the residue with diethyl ether gives 7-chloro-2-hydrazino-3-isobutyl-5-phenyl-3H-1,4-benzodiazepine obtained in forra of crystals. By recrystallization from a mixture yoE chloroform and η-hexane, colorless crystals with a melting point of 168 to 169 ° C. are obtained.
Elementaranalyse:
Berechnet für Ci9H2ICIN4:
C 66,95 H 621
Gefunden:
C 6721 H 6,19Elemental analysis:
Calculated for Ci 9 H 2 ICIN 4 :
C 66.95 H 621
Found:
C 6721 H 6.19
N 16,44
N 16,70
Beispiel 8N 16.44
N 16.70
Example 8
2020th
2525th
Zu einer Suspension von 143 Teilen 2-Amino-7-chlor-S-phenyl-SH-t/t-benzodiazepin^N-oxyd in 400 Raumteilen Methanol werden 12,5 Raumteile 100°/oiges Hydrazinhydrat und 10 Raumteile Methanol, das mit Chlorwasserstoff gesättigt ist, gegeben. Das Gemisch wird 10 Minuten unter Rückfluß erhitzt und die erhaltene Lösung auf die Hälfte des ursprünglichen Volumens eingeengt. Das Konzentrat wird in 500 Raumteile Wasser gegossen und die erhaltene ölige Substanz mit Chloroform extrahiert. Die Chloroformschicbt wird über Natriumsulfat getrocknet und eingedampft. Durch Behandlung des Rückstandes mit Diäthyläther wird 7-Chlor-2-hydrazino-5-phenyl-3H-: l,4-benzodiazepin-4N-oxyd als blaßgelbe pulverförmige Kristalle vom Schmelzpunkt 262-263° C erhalten.To a suspension of 143 parts of 2-amino-7-chloro-S-phenyl-SH-t / t-benzodiazepine ^ N-oxide in 400 parts by volume of methanol, 12.5 parts by volume are 100% Hydrazine hydrate and 10 parts by volume of methanol, which is saturated with hydrogen chloride, are given. The mixture is refluxed for 10 minutes and the resulting solution to half of the original Confined in volume. The concentrate is poured into 500 parts by volume of water and the resulting oily Substance extracted with chloroform. The chloroform slips is dried over sodium sulfate and evaporated. By treating the residue with Diethyl ether becomes 7-chloro-2-hydrazino-5-phenyl-3H-: 1,4-benzodiazepine-4N-oxide as pale yellow powdery form Crystals with a melting point of 262-263 ° C were obtained.
Elementaranalyse:
Berechnet für Ci5HnClN4O:
C 59,90 H 436 N 18,63
Gefunden:
C 60,05 H 4,13 N 18,41Elemental analysis:
Calculated for Ci 5 HnClN 4 O:
C 59.90 H 436 N 18.63
Found:
C 60.05 H 4.13 N 18.41
Zu einem Gemisch von 3 Teilen 2-Amino-7-nitro-5-phenyI-3H-l,4-benzodiazepin-4N-oxyd und 100 Raumteilen Äthanol werden 2£ Raurateile 100%iges Hydrazinhydrat und 1,8 Raumteile Essigsäure gegeben. Das Gemisch wird einige Zeit auf dem Wasserbad leicht erwärmt, wobei eine Lösung intsteht, und etwa 20 Minuten bei Raumtemperatur geiübru Die ausgefällten Kristalle werden abgetrennt und mit Äthanol und dann mit Diäthyläther gewaschen, wobei 2-Hydrazino-7-nitro-5-phenyl-3H-l,4-benzodiazepin-4N-oxyd in Form vct!\ gelben Nadeln vom Schmelzpunkt 176°C (Sinterung) und 226° C (Zers.) erhalten wird.To a mixture of 3 parts of 2-amino-7-nitro-5-phenyI-3H-1,4-benzodiazepine-4N-oxide and 100 parts by volume of ethanol become 2 parts of 100% hydrazine hydrate and 1.8 parts by volume of acetic acid. The mixture becomes light on the water bath for some time heated, with a solution int, and about 20 Minutes at room temperature geiübru The precipitated Crystals are separated off and washed with ethanol and then with diethyl ether, 2-hydrazino-7-nitro-5-phenyl-3H-1,4-benzodiazepine-4N-oxide in the form of yellow needles with a melting point of 176 ° C (sintering) and 226 ° C (dec.).
Elementaranalyse:
Berechnet für Ci5H13N5O3:
C 57,87 H 421 N 22,50
Gefunden:
C 5738 H 4,01 N 22,26Elemental analysis:
Calculated for Ci 5 H 13 N 5 O 3 :
C 57.87 H 421 N 22.50
Found:
C 5738 H 4.01 N 22.26
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19691965894 DE1965894C2 (en) | 1969-11-04 | 1969-11-04 | 2-hydrazino-5-phenyl-3H-1,4-benzodiazepine derivatives and process for their preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19691965894 DE1965894C2 (en) | 1969-11-04 | 1969-11-04 | 2-hydrazino-5-phenyl-3H-1,4-benzodiazepine derivatives and process for their preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
DE1965894A1 DE1965894A1 (en) | 1970-08-20 |
DE1965894C2 true DE1965894C2 (en) | 1983-08-04 |
Family
ID=5755490
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19691965894 Expired DE1965894C2 (en) | 1969-11-04 | 1969-11-04 | 2-hydrazino-5-phenyl-3H-1,4-benzodiazepine derivatives and process for their preparation |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE1965894C2 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1362322A (en) * | 1962-07-10 | 1964-05-29 | Hoffmann La Roche | Process for the preparation of benzodiazepine derivatives |
-
1969
- 1969-11-04 DE DE19691965894 patent/DE1965894C2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DE1965894A1 (en) | 1970-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE1695753A1 (en) | Improvements in the preparation of 4-oxopiperidine compounds and certain new 4-oxopiperidine compounds | |
DE1620694B2 (en) | Process for the preparation of 5-methyl-7-diethylamino-s-triazolo [1,5-a] pyrimidine and its salts with acids | |
DE1518764C3 (en) | S-phenyl-2-oxo-23-dihydro-1H-1 ^ -benzodiazepine-S-carboxylic acid salts and alkyl esters substituted in the 7-position | |
DE2458638C2 (en) | 4'-substituted 2-methyl-3-piperidinopropiophenone derivatives, processes for their production and pharmacological preparations which contain them | |
DE1965894C2 (en) | 2-hydrazino-5-phenyl-3H-1,4-benzodiazepine derivatives and process for their preparation | |
DE3418382A1 (en) | METHOD FOR THE PRODUCTION OF 1,8-DIHYDROXY-10-ACYL-9-ANTHRONES | |
DE1290143B (en) | 2-Oxo-1, 2-dihydro-3H-1, 4-benzodiazepine derivatives | |
DE1944404C3 (en) | Process for the preparation of 5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one derivatives | |
DE2302970C3 (en) | Process for the preparation of 4- (1-substituted-4-piperidylidene) -4H-benzo [4,5] cyclohepta [1,2-b] thiophene-10 (9H) -ones | |
DE1812231B2 (en) | PROCESS FOR THE PREPARATION OF 3ALKYL-5-PHENYL-1,3-DIHYDRO-2H-1,4BENZODIAZEPIN-2-ONE DERIVATIVES | |
DE1811831C3 (en) | Process for the preparation of 5-phenyl-13-dihydro-2H-1,4-benzodiazepin-2-one derivatives | |
DE2265242C2 (en) | Process for the preparation of tautomeric 4-phenyl-1,3-dihydro-2H-1,5-benzodiazepine-2-thiones | |
AT296316B (en) | Process for the preparation of new benzodiazepine derivatives and their N-4-oxides | |
DE1493081A1 (en) | Yloxytrialkylsilanes of the androstane or OEstran series and process for their production | |
DE1795053A1 (en) | Process for the preparation of compounds of the benzodiazepine series | |
AT240373B (en) | Process for the preparation of benzodiazepine derivatives | |
DE1470413A1 (en) | Quaternary ammonium compounds, their manufacture and pharmaceutical preparations | |
DE1933523C (en) | 3-Benzal-thiochroman-4-one-1-oxide | |
AT204547B (en) | Process for the production of new oxyketones | |
DE1445073C (en) | 3H-1,4-Benzodiazepine-4-oxides | |
DE1620496C (en) | 1-pyridyl-3,4-dihydroisoquinolines and a process for their preparation | |
DE568549C (en) | Process for the preparation of 2-alkoxy-5-nitropyridines | |
AT276401B (en) | Process for the preparation of benzodiazepine derivatives | |
DE1545599A1 (en) | Process for the preparation of new 6-hydrazino-pyridazine derivatives and their salts | |
DE1695213A1 (en) | Process for the preparation of benzodiazepine derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8178 | Suspension cancelled | ||
AC | Divided out of |
Ref country code: DE Ref document number: 1955349 Format of ref document f/p: P |
|
D2 | Grant after examination | ||
8364 | No opposition during term of opposition |